CHEK2 and breast cancer: Our findings are in line with literature on breast cancers with heterozygous CHEK2 (g)PVs (10) and show no statistically significant differences in genomic instability features between breast and non-breast cancers of CHEK2-deficient individuals (Supplementary Figure 3, A and B, available online).